Hansard to 11 September 2026 · 28,928 contributions indexed · 1,439 MPs & peers
01 Topic · Healthcare
Vital Signs: Dementia
Change topic · 28 health and social care topics
Healthcare · 22
- Cancer
- Mental health
- Dementia
- Diabetes
- Maternity & neonatal
- Long Covid
- Heart disease & stroke
- Respiratory (asthma/COPD)
- Palliative & end of life care
- Assisted dying
- Children's health
- Rare diseases
- NHS waiting lists
- A&E & ambulance response
- GP access
- Dentistry access
- NHS & care workforce/staffing
- Health inequalities
- Public health & prevention
- Medical ethics & regulation
- Cosmetic procedures & aesthetics
- Plastic & reconstructive surgery
Who is shaping the debate on dementia: in Parliament, in the press, and among the experts the press turns to.
02 Who is talking · pick a lens
03 The signal · Where it is spoken from
245
of 1,439 MPs & peers have spoken on dementia since 9 July 2024 · 423 Commons contributions from 184 constituencies · latest sitting indexed 11 September 2026
Seats shaded by Hansard contributions on this topic. Lines join the 9 MPs in this list to their constituencies; peers have no seat and no line.
- 01—
Baroness MerronMinisterLabour · House of Lords · Parliamentary Under-Secretary (Department of Health and Social Care)52
- 02—
Joe RobertsonConservative · Isle of Wight East · Commons45
- 03—
Dr Danny ChambersSpokespersonLiberal Democrat · Winchester · Commons · Liberal Democrat Spokesperson (Mental Health)36
- 04—
Stephen KinnockCabinetLabour · Aberafan Maesteg · Commons · Secretary of State for Wales36
- 05—
Liz JarvisLiberal Democrat · Eastleigh · Commons33
- 06—
Caroline VoadenSpokespersonLiberal Democrat · South Devon · Commons · Liberal Democrat Spokesperson (Schools)33
- 07—
Lucy PowellCabinetLabour (Co-op) · Manchester Central · Commons · Secretary of State for Education30
- 08—
Stephanie PeacockMinisterLabour · Barnsley South · Commons · Parliamentary Under-Secretary of State (Department for Digital, Culture, Media and Sport)30
- 09—
Dr Luke EvansShadowConservative · Hinckley and Bosworth · Commons · Shadow Minister (Energy Security and Net Zero)30
- 10—
Jim ShannonDemocratic Unionist Party · Strangford · Commons27
Score is a weighted Hansard contribution score for this topic since 9 July 2024. Portraits: UK Parliament Members API. Rank change (▲/▼) is vs. 7 days ago.
Hansard · weekly mentions
102 mentions in the last 8 sitting weeks, 29 in the 8 before
Recess weeks are not counted: sitting weeks are compared with sitting weeks, and the current week is left off until it is complete. Parliament was in recess 27 Jul to 30 Aug 2026. 591 mentions since 9 July 2024.
Press · articles per week
111 articles in 25 weeks, 78 of them in the last five
Source: Guardian archive, trade press and news search: a sample of coverage, not an exhaustive count. Weekly article counts to w/c 7 Sept; weeks not yet ingested are dropped rather than shown as zero.
Parliament · party split
Share of scored contributions
- Labour127 members52%
- Liberal Democrat35 members18%
- Conservative48 members18%
- Crossbench17 members4%
- Others (9 groups)18 members7%
Labour members account for 52% of the scored contributions on this topic, across 13 party groups in both Houses.
Parliament · reach
Members who have spoken
245of 1,439 MPs & peers
17% of the roster has spoken on this topic since 9 July 2024: one square per member, 184 MPs (navy) and 61 peers (cobalt).
Briefing · Parliament
MPs and peers press government on dementia diagnosis rates, data gaps and care funding as treatment era begins
- The inadequacy of dementia data and its consequences for clinical trials was a central theme in the Lords debate on patient data for research on 10 September. Baroness Murphy (Crossbench) described dementia data as being 'in an extremely poor state', citing late identification, poor linkage and inconsistent coding, while Lord Kamall (Conservative) argued that without high-quality, interoperable data, progress on diagnosing and treating dementia 'will stand or fail'.
- In a Lords question session on NHS dementia treatment trials on 22 June, Baroness Merron (Labour) confirmed the government is committed to recovering the dementia diagnosis rate to 66.7% and is developing a modern service framework for frailty and dementia by the end of the year. Baroness Murphy pressed the Minister on the fact that only 30% of dementia cases are ever diagnosed, while Lord Harper (Conservative) questioned whether the steps outlined were adequate to handle new disease-modifying drugs when cleared by NICE.
- The discharge of Isle of Wight dementia patients to mainland care homes was the subject of an adjournment debate on 16 June, in which Richard Quigley (Labour, Isle of Wight West) described a care commissioning model where 87% of care services are commissioned below true cost, and called for funding uplifts to reach frontline providers. Minister Preet Kaur Gill (Labour) acknowledged that being moved away from familiar surroundings can be 'profoundly distressing' and restated local authorities' statutory duty under the Care Act 2014.
- Two new clauses tabled by Joe Robertson (Conservative, Isle of Wight East) during Health Bill committee stages on 16 July would have required the Secretary of State to publish an annual dementia care report covering NHS and social care provision, workforce, post-diagnostic support and care coordination. The government opposed them as unnecessary, with Minister Karin Smyth (Labour, Bristol South) saying she understood the rationale but did not consider the clauses necessary; they were subsequently withdrawn.
- The question of whether dementia care should be funded on the same basis as cancer treatment was raised directly with the Prime Minister on 1 September by Neil Duncan-Jordan (Labour, Poole), who called it a 'fundamental unfairness'. Andy Burnham (Labour, Makerfield) responded that a system that supports people with dementia as well as it treats people with cancer is 'the goal we should be working towards', while Sir Andrew Dilnot, giving evidence during the Health Bill's second sitting on 16 June, described the means-tested funding line as 'arbitrary' and said it is 'making it hard for the NHS to work'.
Verbatim
We identify people too late, if at all. There is poor follow-up and data linkage, and difficulty matching people to the right trials. One problem is that people get referred to memory clinics over here, often remote from hospital services there. That is good for access, but where there are no links to research organisations, diagnosis is rarely followed up and, if you have a mild problem, you are never seen again.
Baroness Murphy · Crossbench, House of Lords · Patient Data: Research · 10 Sept 2026
Read in Hansard (opens in a new tab)The fact that it is dementia and severe arthritis means we have drawn an arbitrary line, and while that line still exists and there is still inadequate funding, even in a means-tested system, we are hamstringing the NHS.
Helen Morgan · Liberal Democrat, North Shropshire · Health Bill (Second sitting) · 16 Jun 2026
Read in Hansard (opens in a new tab)There is a very real fear that when someone is at their most vulnerable, where they live will determine how they are treated and whether they are afforded the dignity they deserve: the dignity of being close to family, of continuity in care, and of remaining in the place they call home.
Richard Quigley · Labour, Isle of Wight West · Isle of Wight Dementia Patients: Discharge to Mainland Care Homes · 16 Jun 2026
Read in Hansard (opens in a new tab)Dementia is not gender neutral. We may not have a cure at the moment, but we can cure the inequity in access to research, clinical trials, early diagnosis and effective treatments. In England, more than 500,000 people now have a recorded diagnosis of dementia, and nearly two-thirds of them are women.
Baroness Nargund · Labour, House of Lords · Modern Service Framework for Dementia and Frailty · 9 Jul 2026
Read in Hansard (opens in a new tab)Without high-quality data and interoperable systems, researchers and clinicians cannot identify patients early, recruit them into trials, evaluate new diagnostics or scale treatments across health and social care. This is not a technical detail; it is a foundation on which meaningful progress to diagnose and treat dementia will stand or fail.
Lord Kamall · Conservative, House of Lords · Patient Data: Research · 10 Sept 2026
Read in Hansard (opens in a new tab)
AI-drafted from 91 Hansard contributions over 34 sitting days · 16 June 2026 to 11 September 2026 · No sittings were recorded between 24 July 2026 and 31 August 2026. · quotes are exact copies of the Hansard record, speakers taken from the record · generated 14 Sept 2026 · how briefings are made
Expert voices · press citations
The most quoted voices on this topic
40 of 109 expert voices, 48 citations across 4 groups. Click a group to open it as a lens on the map.
Clinicians
4 · 4 citationsOpen lens ↑- Prof Guy LeschzinerGuy's and St Thomas' NHS Foundation Trust / King's College London1
- Ann Cohenassociate professor of psychiatry at the University of Pittsburgh1
- Bhaskar SemithaMD, cardiothoracic surgeon with ClinicSpots1
- Dag Aarslandprofessor of old age psychiatry at the Institute of Psychiatry, Psychology and Neuroscience at King's College London1
Academics
24 · 27 citationsOpen lens ↑- Dr. Josef CoreshNYU Grossman School of Medicine / NYU Langone Health3
- Prof Naomi AllenChief Scientist, UK Biobank2
- Dr Richard Oakleyassociate director of research and innovation at Alzheimer's Society1
- Prof Dame Louise Robinsonled the PriDem research at Newcastle University1
- Mika Kivimäki, PhDUniversity College London1
- Prof Charles Swantonco-leader of the Rapid project and deputy clinical director at the Crick1
- Prof Derk-Jan Dijkgroup leader at the UK Dementia Research Institute Centre for Care Research & Technology at Imperial College London and the University of Surrey1
- Professor Alan GowProfessor at Heriot-Watt University1
- Tara Spires-JonesUniversity of Edinburgh1
- Adam GordonProfessor of the Care of Older People at the Academic Centre for Healthy Ageing, Queen Mary University of London, and Chair of Alzheimer's Society's Clinical Advisory Group1
- Adrian Listonimmunologist and professor of pathology at the University of Cambridge1
- Alison Mutchcoroner, senior coroner for South Manchester1
- Andrea Rossoassociate professor of epidemiology at University of Pittsburgh1
- Andrea ZammitStudy author, Rush University Medical Center in Chicago1
- Charles MarshallProfessor of clinical neurology at Queen Mary, University of London1
- Dr Andrew Wallachambulatory care chief medical officer at NYC Health + Hospitals1
- Dr Daniel Du Plessisneuropathology expert1
- Dr Emily SimmondsBioinformatician at the UK Dementia Research Institute at Cardiff University1
- Dr Fred Adomako-BoatengRegional Director of the Ghana Health Service, Ashanti Region1
- Dr George Stothartcognitive neuroscientist at the University of Bath1
- Dr Hafez Adam TaherDirector of Technical Coordination at the Ministry of Health, Ghana1
- Dr Jeffrey CummingsUniversity of Nevada1
- Dr Joy Edwards-Hicksresearcher at the University of Edinburgh who studies how changes in blood metabolites affect the immune system1
- Dr Julian Mutzresearcher at King's College London1
Sector leaders
11 · 16 citationsOpen lens ↑- Professor Martin Green OBEchief executive of Care England and independent sector dementia champion for the Department of Health and Social Care4
- Dr Julia DudleyAlzheimer's Research UK2
- Michelle Dysonchief executive at Alzheimer's Society2
- Dr Sheona ScalesAlzheimer's Research UK1
- Dr Jacqui HanleyAlzheimer's Research UK1
- Hilary Evans-Newton CBEChief Executive, Alzheimer's Research UK1
- Michelle Dyson CBCEO, Alzheimer's Society1
- Andrea Laytongeneral manager at Barton Manor, part of Danforth Care Homes1
- Anna ClementsHead of dementia at Age Scotland1
- David Thomashead of policy and public affairs at Alzheimer's Research UK1
- Dr Isolde RadfordSenior policy manager at Alzheimer's Research UK1
Regulators & officials
1 · 1 citationOpen lens ↑- Helen KnightNational Institute for Health and Care Excellence (NICE)1
Methodology
How Vital Signs ranks
Parliament. Every Hansard contribution on a topic since 9 July 2024 is scored by type and summed per member; the map colours each constituency by how often its MP has raised the topic. Peers sit in no constituency and are ranked but not mapped.
Press.Bylines rank journalists and quotations rank expert voices, across the Guardian archive and trade press Vital Signs has read. A voice’s pin marks its organisation’s base, never the person’s home.
Briefings. Drafted by an AI model from the underlying Hansard text or articles. Every quotation in a Parliament briefing is an exact copy of the Hansard record and linked to it; press quotations are as the linked articles reported them. The speaker is always taken from the record, not the model.